Navigation Links
TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
Date:5/6/2009

SAN DIEGO, May 6 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, has launched a new Hot Start PCR reagent - CleanAmp(TM) dNTPs.

CleanAmp(TM) dNTPs offer a less expensive solution to improved hot start PCR results. Using CleanAmp(TM) dNTPs allows precise control at the start of PCR thermal cycling by blocking DNA polymerase nucleotide incorporation until heat activated. The temperature dependent control of DNA polymerase extension vastly reduces mis-priming, primer dimer formation and other common deleterious effects.

"We believe CleanAmp(TM) dNTPs will become the less expensive approach to high stringency PCR," said Dr. Richard Hogrefe, CEO and President of TriLink. "TriLink now offers two unique hot start PCR solutions: CleanAmp(TM) dNTPs and CleanAmp(TM) Primers. The CleanAmp(TM) Primers will solve specific assay issues whereas CleanAmp(TM) dNTPs will be a more general solution. Either product will provide a very cost effective solution when compared to the modified enzymes available on the market."

About TriLink

TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, nucleoside triphosphates and CleanAmp(TM) Products for research and diagnostic laboratories. In addition, custom chemistry, contract research services and GMP production facilities for oligos and small molecules are offered. TriLink's solutions help advance drug discovery and biomedical research. For more information visit www.trilinkbiotech.com or contact:

    TriLink BioTechnologies, Inc.

    Shawna Leaver, 858-546-0004

    sleaver@trilinkbiotech.com


'/>"/>
SOURCE TriLink BioTechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
2. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
3. AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe
4. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
5. Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory
6. Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
7. Lenetix Launches Screening Study of New Down Syndrome Test
8. AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
9. Senetek PLC Launches Dedicated Pyratine-6(TM) Website
10. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
11. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. Antunes,  ... Achievement Award" from the Journal of Drugs in ... & Clinical Conference (ODAC). The event is January 17-20, 2014, at ... Florida . The ODAC is ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... for Cinryze for Acute HAE Indication is June 3, 2009 ... Incorporated (Nasdaq: VPHM ) today announced that the ... for Cinryze C1 Inhibitor (human) as a treatment for acute ... Application (sBLA), submitted to the FDA on December 1, ...
... CVS Caremark Proactive Pharmacy Care approach designed to help ... costs WOONSOCKET, R.I., Feb. 3 /PRNewswire/ ... (NYSE: CVS ) found that nearly half ... adherent to recommended drug therapies, significantly increasing their risk ...
Cached Medicine Technology:FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
(Date:4/18/2014)... have made a brain-related discovery that could revolutionize ... This discovery opens up the possibility that environmental ... specific brain activity that the researchers have identified ... Journal of Neuroscience has just published a ... associate professor of psychology and his doctoral student ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... specifically associated with the risk of a difficult-to-diagnose ... of all breast cancer cases. , The largest ... invasive lobular carcinoma, gives researchers important clues to ... breast cancer, which can be missed through screening. ... journal PloS Genetics , was co-led by ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... , MONTGOMERY, Ala., ... LTCi Solutions from United of Omaha, a Mutual of Omaha company. ... products to suit producer,s sales needs - all of which offer ... on the first day of qualified need with no elimination period. ...
... , OREM, Utah, Dec. 9 LookingYourBest.com, ... Cosmetic and Plastic Surgeons , offers more than just a bold ... , The first aspect of the new LookingYourBest.com that will surely ... old, sterile layout with its pastel colors blending out to the ...
... , ARLINGTON, Va., Dec. 9 ... the Healthcare Distribution Management Association (HDMA), issued the following ... Patient Protection and Affordable Care Act, which would allow ... prescription drugs from foreign countries, as Senator Dorgan and ...
... ... , ... December 9, 2009 -- In 2008, LQ Performance Strategies predicted its core business, custom ... the economic climate deteriorated. At the same time, it recognized the opportunity to ...
... Web ... into likely employer compliance issues. , ... Minneapolis, MN (PRWEB) December 9, 2009 -- Ceridian Corporation, a ... filing and payroll outsourcing solutions, announced today it will present the first ...
... ... announce the launch of Educus ICD-9 Complete Reference – a ... the Apple iPhone, iPod touch, and Android-powered phones. The application provides ... the user can either search through all of the codes or the ...
Cached Medicine News:Health News:AIMS Benefit Solutions Offering Long-Term Care Insurance Featuring CASH-First(TM) from United of Omaha 2Health News:AIMS Benefit Solutions Offering Long-Term Care Insurance Featuring CASH-First(TM) from United of Omaha 3Health News:Your Online Resource For Plastic Surgery Information 2Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:LQ Performance Strategies Launches the LQ Solutions Vault Providing On Demand Strategic Corporate Training Products and Services 2Health News:LQ Performance Strategies Launches the LQ Solutions Vault Providing On Demand Strategic Corporate Training Products and Services 3Health News:Ceridian Web Forum to Prepare Employers for Health Care Reform 2Health News:Ceridian Web Forum to Prepare Employers for Health Care Reform 3Health News:Educus.com Launches ICD-9 app for Apple iPhone and Android Devices 2Health News:Educus.com Launches ICD-9 app for Apple iPhone and Android Devices 3
... The IsoFlex S lead's small ... ease implantation and lower the ... smaller, more tortuous vessels. Atrial ... and fixation options combine to ...
Unipolar Atrial "J" Lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: